CN105233290A - C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 - Google Patents
C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 Download PDFInfo
- Publication number
- CN105233290A CN105233290A CN201510809837.5A CN201510809837A CN105233290A CN 105233290 A CN105233290 A CN 105233290A CN 201510809837 A CN201510809837 A CN 201510809837A CN 105233290 A CN105233290 A CN 105233290A
- Authority
- CN
- China
- Prior art keywords
- c22orf26
- gene
- parkinson
- expression
- seqidno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组分 | 加入量 |
2×mix | 10μl |
上游引物(10uM) | 0.5μl |
下游引物(10uM) | 0.5μl |
模板 | 2μl |
加入灭菌蒸馏水 | 至25μl |
组别 | C22ORF26/actin相对浓度比值(均数±标准差) |
空白对照组 | 1.0 |
脂质体转染组 | 1.0138±0.0874 |
非特异性转染组 | 0.9976±0.0723 |
C22ORF26-siRNA1组 | 0.6905±0.0311 |
C22ORF26-siRNA2组 | 0.1692±0.0216 |
C22ORF26-siRNA3组 | 0.4821±0.0128 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510809837.5A CN105233290B (zh) | 2015-07-31 | 2015-11-20 | C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510464016 | 2015-07-31 | ||
CN2015104640162 | 2015-07-31 | ||
CN201510809837.5A CN105233290B (zh) | 2015-07-31 | 2015-11-20 | C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105233290A true CN105233290A (zh) | 2016-01-13 |
CN105233290B CN105233290B (zh) | 2018-02-09 |
Family
ID=55031276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510809837.5A Active CN105233290B (zh) | 2015-07-31 | 2015-11-20 | C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105233290B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108060223A (zh) * | 2017-12-29 | 2018-05-22 | 北京泱深生物信息技术有限公司 | Atf2基因的新应用 |
CN109468373A (zh) * | 2018-12-24 | 2019-03-15 | 潘伟 | 一种与帕金森发生发展相关的生物标志物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011046635A1 (en) * | 2009-10-14 | 2011-04-21 | The Johns Hopkins University | Differentially methylated regions of reprogrammed induced pluripotent stem cells, method and compositions thereof |
WO2012087983A1 (en) * | 2010-12-20 | 2012-06-28 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
-
2015
- 2015-11-20 CN CN201510809837.5A patent/CN105233290B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011046635A1 (en) * | 2009-10-14 | 2011-04-21 | The Johns Hopkins University | Differentially methylated regions of reprogrammed induced pluripotent stem cells, method and compositions thereof |
WO2012087983A1 (en) * | 2010-12-20 | 2012-06-28 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108060223A (zh) * | 2017-12-29 | 2018-05-22 | 北京泱深生物信息技术有限公司 | Atf2基因的新应用 |
CN109468373A (zh) * | 2018-12-24 | 2019-03-15 | 潘伟 | 一种与帕金森发生发展相关的生物标志物 |
Also Published As
Publication number | Publication date |
---|---|
CN105233290B (zh) | 2018-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110036056A (ko) | 전이와 관련된 시그너처 및 결정인자 및 이의 사용 방법 | |
EP2910948B1 (en) | Novel cancer marker and utilization thereof | |
CN109609651B (zh) | 一种诊治胶质瘤的分子标志物及其应用 | |
CN105063194B (zh) | 一种帕金森的诊断标志物及其应用 | |
CN104962658B (zh) | Myoz1基因及其表达产物在帕金森病诊治中的应用 | |
CN112501299A (zh) | 一种用于预测肝癌复发和转移的方法及应用 | |
CN105483275B (zh) | mir-1299及其成熟miRNA的新用途 | |
CN105233290A (zh) | C22orf26基因及其表达产物在制备帕金森诊疗试剂中的应用 | |
CN105288659B (zh) | Tenm1基因及其表达产物在诊治乳头状腺癌的应用 | |
CN105349641A (zh) | 急性心肌梗死相关基因serpinb13及其应用 | |
CN108034707B (zh) | Spag7基因在制备老年痴呆诊断制剂中的应用 | |
CN107937515B (zh) | 一种阿尔茨海默的诊疗基因靶点及其应用 | |
CN104984363B (zh) | Zmym1在制备帕金森诊疗试剂中的应用 | |
CN107779503A (zh) | 阿尔茨海默相关的差异表达基因及其应用 | |
CN111471683B (zh) | miR-93-5p作为诊断和治疗胃癌标志物的应用 | |
CN108034713A (zh) | 绝经后骨质疏松症诊疗靶点及其应用 | |
CN105695617A (zh) | 乳头状癌的肿瘤标志物及其应用 | |
US20220135979A1 (en) | Diagnosis and treatment of medulloblastoma | |
CN107881240B (zh) | 骨肉瘤的诊治标志物 | |
CN106399485A (zh) | 一种在舌鳞癌癌旁组织中高表达的基因及其应用 | |
CN105506171A (zh) | Lyrm2基因及其表达产物的新用途 | |
CN105648079B (zh) | 一种骨质疏松血液检测靶点及其应用 | |
CN105597109B (zh) | 原发骨肉瘤的诊治分子标记 | |
CN104740649B (zh) | Plekha5在制备肿瘤诊断试剂中的应用 | |
US11497817B2 (en) | Senile dementia treatment formulation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: C22orf26 gene and application of expression product of C22orf26 gene to preparing Parkinson diagnosis and treatment preparation Effective date of registration: 20181225 Granted publication date: 20180209 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191206 Granted publication date: 20180209 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191227 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Patentee after: Qingdao Yangshen biomedical Co., Ltd Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Patentee before: Beijing Yang Shen biology information technology company limited |
|
TR01 | Transfer of patent right |